Clinical Trials Directory

Trials / Completed

CompletedNCT01096433

Circadian Variations of Prostaglandin in Sleep Apnea

Association of Circadian Variations,Sleep Architecture, Hypertension, and Prostaglandin in Sleep Apnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Kyoto University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the associations of circadian variations, sleep architecture, hypertension and prostanoids in the patients with sleep apnea. In addition, the patients introduced to continuous positive airway pressure(CPAP) treatment, the effects of CPAP are also evaluated.

Detailed description

Obstructive sleep apnea (OSA) is characterized by repetitive episodes of upper airway obstruction during sleep that provoke frequents arousals, sleep fragmentation, oxygen desaturation, and excessive daytime sleepiness. OSA may contribute to the development of systemic hypertension, cardiovascular disease. Many studies has reported a crucial role for the prostaglandin D system in sleep regulation. In addition, it has been described urinary or blood levels of prostaglandins was higher in the patients with hypertension, diabetes mellitus, and these values were associated with the severity of coronary artery disease. However, the relation between alterations of prostaglandin D system and sleep architecture, sleepiness, and clinical outcomes such as hypertension, arteriosclerosis in the patients with OSA are not known. Additionally, after CPAP treatment, we will investigate the association between change of prostaglandin system and sleep architecture, sleepiness, clinical outcomes.

Conditions

Interventions

TypeNameDescription
DEVICECPAP treatmentmaintains upper airway patency and minimizes the obstructive events

Timeline

Start date
2010-05-01
Primary completion
2011-10-01
Completion
2012-01-01
First posted
2010-03-31
Last updated
2012-01-26

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01096433. Inclusion in this directory is not an endorsement.